Demanda de medicamentos sin receta: evaluación de la intervención farmacéutica / Demand for drugs without prescription: Evaluation of pharmaceutical intervention

Introducción: La modificación de los usos y actitudes de los demandantes de dispensación de medicamentos que precisan receta médica sin presentarla, es un campo donde el farmacéutico comunitario, desde su responsabilidad profesional, puede contribuir a obtener importantes resultados en la consecución de su uso correcto.Objetivo: Evaluar el resultado de la intervención del farmacéutico en la demanda de medicamentos (ibuprofeno y paracetamol) sin presentar receta médica en presentaciones que la requieren. Método: Diseño: estudio experimental transversal aleatorizado con intervención farmacéutica mediante educación sanitaria.Emplazamiento: nueve farmacias de Pontevedra y Ourense. Octubre-noviembre de 2019.Participantes: usuarios de la farmacia que solicitaban sin receta presentaciones de paracetamol o ibuprofeno que la requerían.Mediciones principales: número de solicitudes, problemas de salud y motivos, aceptación o no de una alternativa de medicamento sinreceta (MSR).Resultados:Se registraron 424 peticiones, 303 (71,5%) aceptaron la dispensación del MSR. Ibuprofeno 600 mg fue el principio activo más solicitado (73,3%) y la automedicación el principal motivo de petición sin receta (89,9%). Entre los problemas de salud referidos destacó el dolor de cabeza (22,9%). No se encontraron diferencias significativas entre el resultado de la intervención y el medicamento solicitado, el sexo, el motivo, ni el problema de salud que originó la solicitud. Sí entre edad de los pacientes, medicamento solicitado y resultado de la intervención. 30 (14,2%) pacientes fueron derivados al médico.Conclusiones:La actuación del farmacéutico en el cambio a un medicamento sin receta logró una alta aceptación por los pacientes, lo que contribuye a su uso adecuado.(AU)

Introduction: The change in the usage and the attitudes of the petitioners who ask for the dispensing of medications that require a medical prescription without deliver it, is a field in which the community pharmacist, from his or her professional responsibility, can contribute to obtain important outcomes in the achievement of their correct usage.Objective:This study pursues to evaluate the result of the pharmacist intervention on the demand for drugs (ibuprofen and paracetamol) without delivering a medical prescription in cases in which it is needed. Method: Design: It was carried out an experimental, cross-sectional and randomized study with pharmaceutical intervention through health education.Location: nine pharmacies from Pontevedra and Ourense. October –November 2019.Participants: pharmacy users that ask for paracetamol or ibuprofeno without having a medical prescription although it was needed. Main measurements: number of requests, health problems and causes, acceptance or not of an alternative, an over the counter (OTC) drug. Results: 424 requests were registered, 303 (71.5%) accepted the OTC dispensation. Ibuprofeno 600 mg was the most requested active ingredient (73.3%) and self-medication the main cause of request without a prescription (89.9%). Among the health problems referred, headache stood out (22.9%). There were not found significant differences between the outcome of the intervention and the requested medication, the sex, the reason, or the health problem that was the origin of the request. On the other hand, important differences were found in the age of the patients, the requested medication and the result of the intervention. 30 (14.2%) patients were referred to the doctor. Conclusions: The intervention of the pharmacist in the change to an over the counter drug achieved a high acceptance from the patients, which contributes to their correct usage.(AU)

Recomendaciones de la Sociedad Española de Diabetes (SED) para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: Actualización 2018 / Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update

La diabetes mellitus tipo 2 (DM2) es un problema de dimensiones globales por su alta y creciente prevalencia en todo el mundo y por los costes personales y económicos asociados a ella. Un tratamiento adecuado ha demostrado reducir la mortalidad y las complicaciones asociadas. Recientemente se han incluido nuevos conceptos en la práctica clínica habitual y en el árbol de decisión de la terapia farmacológica de la DM2. Por ello, la Sociedad Española de Diabetes (SED) encargó al Grupo de Trabajo de Consensos y Guías Clínicas actualizar el documento de 2010 «Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo2». Entre los aspectos novedosos se incluyen nueve características para describir a cada grupo farmacológico: eficacia, riesgo de hipoglucemia, efectos en el peso corporal, efecto demostrado en el riesgo cardiovascular, nefroprotección, limitación de uso en la insuficiencia renal, frecuencia de los efectos secundarios, complejidad y coste. Así mismo, se detallan las opciones de combinación y se desarrollan el inicio y el ajuste de las terapias inyectables disponibles

Type 2 diabetes mellitus (DM2) has become a problem of global dimensions by their high and growing prevalence worldwide and the personal and economic costs associated with it. Correct treatment can reduce mortality and associated complications. New concepts have recently been included in routine clinical practice and have changed the algorithm of DM2 pharmacological therapy. Therefore, the Spanish Society of Diabetes (SED) entrusted to the Working Group of Consensus and Clinical Guidelines an update of the 2010 document Recommendations for Pharmacological Treatment of Hyperglycemia in Diabetes type2. Novel aspects include nine characteristics to describe each drug group: efficiency, the risk of hypoglycemia, effects on body weight, the demonstrated effect in cardiovascular risk, nephroprotection, limitation of use in renal insufficiency, the rate of secondary effects, complexity and costs. Additionally, the document details combination options, and develop the start and adjustment of available injectable therapies

Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update. / Recomendaciones de la Sociedad Española de Diabetes (SED) para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: Actualización 2018.

Type 2 diabetes mellitus (DM2) has become a problem of global dimensions by their high and growing prevalence worldwide and the personal and economic costs associated with it. Correct treatment can reduce mortality and associated complications. New concepts have recently been included in routine clinical practice and have changed the algorithm of DM2 pharmacological therapy. Therefore, the Spanish Society of Diabetes (SED) entrusted to the Working Group of Consensus and Clinical Guidelines an update of the 2010 document Recommendations for Pharmacological Treatment of Hyperglycemia in Diabetes type2. Novel aspects include nine characteristics to describe each drug group: efficiency, the risk of hypoglycemia, effects on body weight, the demonstrated effect in cardiovascular risk, nephroprotection, limitation of use in renal insufficiency, the rate of secondary effects, complexity and costs. Additionally, the document details combination options, and develop the start and adjustment of available injectable therapies.

Consenso sobre tratamiento con insulina en la diabetes tipo 2 / Consensus on insulin treatment in type 2 diabetes

No disponible

Evaluación en farmacias comunitarias del estado nutricional de mayores de 65 años / Assessment of the nutritional condition of over 65s in community pharmacies

Objetivos: Evaluar el estado nutricional de mayores de 65 años con diabetes, que acuden a la farmacia comunitaria y compararlo con el de personas no diabéticas. Método: Estudio observacional-transversal en farmacias españolas por farmacéuticos socios de SEFAC, de 9 de noviembre a 9 de diciembre de 2015. Criterios de Inclusión: ≥65 años, en dos grupos: diabéticos y no diabéticos. Variables: características antropométricas, altura suelo-rodilla (cm), circunferencia braquial (cm), circunferencia de la pantorrilla (cm), diabetes (SÍ/NO) y estado nutricional (cuestionario Mini Nutritional Assessment). Resultados: 1.078 mayores, 652 (60,5%) mujeres de 75,5±7,4 años, 461 (42,8%) diabéticos. 73,4% con sobrepeso/obesidad. IMC=28,6±4,8 sin diferencias significativas entre sexos, mayor en diabéticos (29,0±4,8 vs 28,3±4,8 p=0,0173). 7,5% de diabéticos malnutridos frente al 6,5% de no diabéticos. 39,2% de diabéticos en riesgo de malnutrición frente al 29,8% de no diabéticos. El porcentaje de mujeres en riesgo de malnutrición y/o malnutrición es superior al de hombres (46,3% vs 32,4% p<0,0001). Mayor en mujeres diabéticas frente no diabéticas (52,4% vs 39,3% p=0,0075). 73,1% de diabéticos consideran que tienen problemas de nutrición frente al 80,7% de los no diabéticos p=0,0132. El 30,0% de los diabéticos consideran mejor su estado de salud frente al 45,9% de los no diabéticos. Conclusiones: El 82% de mayores de 65 años presenta malnutrición y/o riesgo de malnutrición, mayor en diabéticos que en no diabéticos y en mujeres que en hombres. 3 de cada 4 mayores de 65 años tienen sobrepeso u obesidad, mayor en hombres que en mujeres, y entre diabéticos que en no diabéticos (AU)

Objectives: To assess the nutritional condition of over 65s with diabetes that go community pharmacies, and compare it to individuals without diabetes. Method: Observational-transversal study in Spanish pharmacies by pharmacists that are SEFAC partners, from November 9 to December 9 2015. Inclusion criteria: ≥65 years old, in two groups: diabetic and non-diabetic. Variables: anthropometric characteristics, floor-knee distance (cm), brachial circumference (cm), calf circumference (cm), diabetes (YES/NO) and nutritional condition (Mini Nutritional Assessment). Results: 1078 elderly; 652 (60.5%) women, 75.5±7.4 years old; 461 (42.8%) diabetic. 73.4% overweight/obese. BMI=28.6±4.8 with no significant differences between genders; higher in diabetics (29.0±4.8 vs. 28.3±4.8 p=0.0173). 7.5% of diabetics presented symptoms of malnutrition vs. 6.5% of non-diabetics. 39.2% of diabetics at risk of malnutrition vs. 29.8% of non-diabetics. There were more women at risk of malnutrition and/or presenting symptoms of malnutrition than men (46.3% vs. 32.4% p>0.0001). Higher in diabetic women than in non-diabetic women (52.4% vs. 39.3% p=0.0075). 73.1% of diabetics believe they suffer from nutritional issues vs. 80.7% of non-diabetics p=0.0132. 30.0% of diabetics believe their health is better vs. 45.9% of non-diabetics. Conclusions: Eighty-two percent of over 65s present symptoms of malnutrition and/or are at risk of malnutrition; the rate is higher among diabetics than non-diabetics and among women than men. Three in every four over 65s are overweight or obese; the rate is higher in men than women and in diabetics than non-diabetics (AU)

Detección de personas en riesgo de padecer diabetes en farmacias comunitarias de Pontevedra (DEDIPO) / Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO)

Objetivo: Pilotar una actividad profesional consistente en la detección de personas en riesgo de padecer diabetes o alteraciones del metabolismo de los hidratos de carbono y derivación para posible diagnóstico en los centros de salud. Comprobación del número de diagnósticos y evaluación del coste para la farmacia. Métodos: Estudio observacional transversal en farmacias comunitarias de Pontevedra en septiembre-octubre de 2014. Cuestionario Findrisc a usuarios de la farmacia con más de 18 años. Con Findrisc ≥ 15 determinación de la glucemia basal capilar y derivación al médico con ≥ 110mg/dL. Variables principales: puntos en cuestionario Findrisc, número de diagnósticos de diabetes, coste del servicio. Las diferencias entre grupos se calcularon con el test de chi-cuadrado, t de Student o test de Wilcoxon. Resultados: El estudio se realizó en 180 farmacias. La muestra incluyó a 4.222 usuarios. De ellos, 992 (23,5%) tenían alto o muy alto riesgo de diabetes (F≥15). Se realizaron 1.060 test de glucemia basal capilar, con un resultado medio de 110,2 (DE=20,4)mg/dL (56-254). De los 384 (9,1%) sujetos derivados al médico, el Servicio Gallego de Salud envió información de 83: 28 (33,7%) diagnosticados de diabetes (3,1% de la muestra) y 26 (31,3%) de prediabetes (2,8%). El coste por sujeto diagnosticado fue de 184,22 € y por sujeto con diabetes o prediabetes fue de 96,86 €. Conclusiones: El número de diagnósticos de nuevos pacientes diabéticos, 3,1% de la muestra total, muestra la alta eficiencia de un programa de cribado para diabéticos ocultos realizado en farmacias comunitarias como el que aquí se presenta

Objective: The aim of this study was to detect people at risk of suffering diabetes or changes in carbohydrate metabolism and to refer them for possible diagnosis to health care centres. The number of diagnoses and costs for the pharmacy were recorded. Methods: A cross-sectional, observational study was conducted in community pharmacies in Pontevedra in September-October of 2014. The Findrisc questionnaire was completed by pharmacy users over 18 years old. If Findrisc score was ≥ 15, capillary blood glucose was measured, and the participant was referred to a physician if the value was ≥ 110mg/dL. The main variables included score in the Findrisc questionnaire, number of diabetes diagnosed, and cost of the service. Differences between the groups were calculated using a Chi-squared test, a Student's t test, and/or a Wilcoxon test. Results: This study was conducted in 180 pharmacies on a sample of 4,222 users, including 992 (23.5%) with a high or very high risk of diabetes (F≥15). In the 1,060 basal capillary blood glucose tests performed, mean glucose level was 110.2 (SD=20.4) mg/dL (56-254). The Galician Health Service sent information about 83 of the 384 (9.1%) subjects referred to a physician: 28 (33.7%) of them were diagnosed with diabetes (3.1% of the sample), and 26 (31.3%) were diagnosed with prediabetes (2.8% of the sample). Cost per diagnosed subject was €184.22 per subject with diabetes and €96.86 per subject with prediabetes. Conclusions: The proportion of subjects with new diagnosis of diabetes (3.1%) shows the high efficiency of a screening program for hidden diabetics implemented at community pharmacies as the one presented here (AU)

Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO). / Detección de personas en riesgo de padecer diabetes en farmacias comunitarias de Pontevedra (DEDIPO).

OBJECTIVE: The aim of this study was to detect people at risk of suffering diabetes or changes in carbohydrate metabolism and to refer them for possible diagnosis to health care centres. The number of diagnoses and costs for the pharmacy were recorded. METHODS: A cross-sectional, observational study was conducted in community pharmacies in Pontevedra in September-October of 2014. The Findrisc questionnaire was completed by pharmacy users over 18 years old. If Findrisc score was ≥ 15, capillary blood glucose was measured, and the participant was referred to a physician if the value was ≥110mg/dL. The main variables included score in the Findrisc questionnaire, number of diabetes diagnosed, and cost of the service. Differences between the groups were calculated using a Chi-squared test, a Student's t test, and/or a Wilcoxon test. RESULTS: This study was conducted in 180 pharmacies on a sample of 4,222 users, including 992 (23.5%) with a high or very high risk of diabetes (F≥15). In the 1,060 basal capillary blood glucose tests performed, mean glucose level was 110.2 (SD=20.4)mg/dL (56-254). The Galician Health Service sent information about 83 of the 384 (9.1%) subjects referred to a physician: 28 (33.7%) of them were diagnosed with diabetes (3.1% of the sample), and 26 (31.3%) were diagnosed with prediabetes (2.8% of the sample). Cost per diagnosed subject was € 184.22 per subject with diabetes and € 96.86 per subject with prediabetes. CONCLUSIONS: The proportion of subjects with new diagnosis of diabetes (3.1%) shows the high efficiency of a screening program for hidden diabetics implemented at community pharmacies as the one presented here.

La diabetes en España desde la perspectiva de la farmacia comunitaria: conocimiento, cumplimiento y satisfacción con el tratamiento / Diabetes in Spain from the perspective of the community pharmacy: knowledge, compliance, and satisfaction with treatment

No disponible

Community pharmacy-based research in Spain (1995-2005): a bibliometric study

Only one study evaluated the scientific activity in community pharmacies in Spain, and it was restricted to articles published in just two journals. Objective: To assess the scientific activity in community pharmacies in Spain through a bibliometric analysis of the original papers published during the years 1995-2005. Methods: IPA, MEDLINE, CSIC database and the journals Seguimiento Farmacoterapéutico y Pharmaceutical Care España were used as data sources. Production indicators, consumption indicators and the impact factor (IF) as a repercussion index were analyzed. Results: 122 articles were included in the review. The articles were published in 12 journals, 78.7% of them in Pharmaceutical Care España and Seguimiento Farmacoterapéutico. The mean number of authors per article was 4.2 (SD=2.1). The transitivity index was 71.3%. The total number of references cited in the articles was 2110. The mean number of references per article was 17.3 SD=9.3. The value of the insularity index was 57.6%. Self citation was 6.8% and the Price index was 66.5%. No impact factor was available for 6 journals. Conclusions: Publication of articles on community pharmacy-based research in Spain has undergone an important increase in the last 5 years. The existence of authors who publish very few studies, the high insularity index and the lack of randomized, controlled trials may be considered as negative indicators in community pharmacy-based research in Spain (AU)

Sólo existe un estudio bibliométrico conocido sobre investigación en farmacia comunitaria en España, y estaba centrado en los trabajos publicados únicamente en dos revistas. Objetivo: Evaluar la actividad científica en investigación en farmacia comunitaria en España realizando un análisis bibliométrico de los artículos originales publicados entre los años 1995-2005. Métodos: Se utilizaron como fuentes de datos IPA, MEDLINE, la base de datos del CSIC y las revistas Seguimiento Farmacoterapéutico y Pharmaceutical Care España. Se analizaron indicadores de producción, indicadores de consumo e indicadores de repercusión de los artículos publicados. Resultados: Se incluyeron 122 artículos en la revisión. Los artículos fueron publicados en 12 revistas, el 78,7% en Pharmaceutical Care España y Seguimiento Farmacoterapéutico. El número medio de autores por artículo fue 4,2 (DE=2,1). El índice de transitoriedad fue de 71,3%. El número total de referencias encontradas en los artículos fue de 2110 (17,3 DE=9,3 por artículo). El índice de aislamiento fue de 57,6%, el porcentaje de autocitación de 6,8% y el índice de Price de 66,5%. No se pudo estudiar el FI de 6 revistas. Conclusiones: La publicación de artículos de investigación en la farmacia comunitaria en España ha experimentado un crecimiento importante en los últimos 5 años. La existencia de autores que publican muy poco, el elevado índice de aislamiento y la falta de estudios experimentales controlados y aleatorizados pueden considerarse como indicadores negativos de la investigación en farmacia comunitaria en España (AU)

Community pharmacy-based research in Spain (1995-2005): A bibliometric study.

UNLABELLED: Only one study evaluated the scientific activity in community pharmacies in Spain, and it was restricted to articles published in just two journals. OBJECTIVE: To assess the scientific activity in community pharmacies in Spain through a bibliometric analysis of the original papers published during the years 1995-2005. METHODS: IPA, MEDLINE, CSIC database and the journals Seguimiento Farmacoterapéutico y Pharmaceutical Care España were used as data sources. Production indicators, consumption indicators and the impact factor (IF) as a repercussion index were analyzed. RESULTS: 122 articles were included in the review. The articles were published in 12 journals, 78.7% of them in Pharmaceutical Care España and Seguimiento Farmacoterapéutico. The mean number of authors per article was 4.2 (SD=2.1). The transitivity index was 71.3%. The total number of references cited in the articles was 2110. The mean number of references per article was 17.3 SD=9.3. The value of the insularity index was 57.6%. Self citation was 6.8% and the Price index was 66.5%. No impact factor was available for 6 journals. CONCLUSIONS: Publication of articles on community pharmacy-based research in Spain has undergone an important increase in the last 5 years. The existence of authors who publish very few studies, the high insularity index and the lack of randomized, controlled trials may be considered as negative indicators in community pharmacy-based research in Spain.

Diseño y validación de un cuestionario de conocimiento sobre diabetes en pacientes de farmacia comunitaria / Design and validation of a knowledge questionarie regarding diabetes among patients attending a community Pharmacy Office

Objetivo: Diseñar y validar un cuestionario que permita evaluar el conocimiento que tienen los pacientes diabéticos sobre su enfermedad. Comparar la validez de dos formas de puntuación. Diseño: Estudio observacional transversal en 15 farmacias comunitarias de Pontevedra y Ourense. Método: Se desarrolló un cuestionario de 18 ítems de conocimiento sobre diabetes y se aplicó a 173 pacientes seleccionados mediante aleatorización sistemática entre los usuarios de farmacias comunitarias mayores de edad y con diabetes mellitus. Se determinó la fiabilidad mediante el índice de consistencia interna (a de Cronbach) y el coeficiente de correlación intraclase (CI), la reproducibilidad con el método de test-retest y la validez de contenido evaluada por expertos. Análisis estadístico para sensibilidad alfa de 95% y significación de p<0,05. Resultados: La dificultad media del cuestionario fue de moderada-fácil. Consistencia Interna: a=0,72; CI=0,76. La correlación entre el cuestionario sin ponderar y el cuestionario ponderado es de r=0,93 y Rho=0,95 a nivel global, y r=0,84-0,95 y Rho=0,87-0,99 a nivel de los subgrupos de ítems (p<0,0001 en todos los casos). Test-retest: r=0,82 y Rho=0, 75. La valoración por expertos fue superior a 4,4 sobre 5. Conclusiones: Se ha obtenido un cuestionario para medición del nivel de conocimientos sobre diabetes con fiabilidad, reproducibilidad y validez óptima, siendo mejor la ponderación y, resultando de su aplicación un nivel bajo de conocimientos de los enfermos (AU)

Objective: To designe and to validate a questionnaire in order to evaluate diabetics patients knowledge about their disease. To compare two ways to score the results. Designe: A transversal observational study on l5 community pharmacies of Pontevedra and Orense provinces. Method: A questionnaire of 18 questions on diabetic knowledge was developed and applied to 173 adult diabetic patients randomly selected among the users of the community pharmacies. The feasibility was determined by the intern consistency index (a of Cronbach) and the interclass correlation coefficient (Cl), reproductibility was determined by the test-retest method and the validity by experts. Statistical analysis for a sensibility alfa of 95% and significance of p<0,05. Results: The medium of difficulty of the questionnaire was moderate-easy. intern consistency: 06:0. 72; Cl=0. 76. The correlation between the questionnaire non balanced and the questionnaire balanced was r=0.93 and Rho=0.95 at a global level; and r=0.84-0.95 and Rho=0.87-0.99 at subgroups level of items (p<0,000l in all cases). Test-retest: r=0.82 and Rho=0. 75. The evaluation by experts was higher than 4.4 over 5. Conclusions: A questionnaire to measure the level of knowledge on diabetes mellitus was obtained with feasibility, reproductivity, and optimal validity, being better the balanced and the result of its application shows a low level of knowledge by the patients (AU)

Detección de diabéticos no diagnosticados en las farmacias comunitarias de la provincia de Pontevedra / Screening of undiagnosed diabetic patients in community-based pharmacies in the province of Pontevedra (Spain)

En la semana del 4 al 9 de junio de 2001, el Colegio de Farmacéuticos de Pontevedra, en colaboración con el Servicio de Endocrinologío y Nutrición del Hospital Xeral-Cíes de Vigo desarrolló una campaña de detección de diabéticos no diagnosticados en las farmacias de la provincia de Pontevedra. Se plantearon como objetivos evaluar la participación del farmacéutico comunitario en programas de educación para la salud y detección precoz de patologías de amplia prevalencia, evaluar la utilidad de los criterios de selección empleados y la influencia de los factores de riesgo, con el fin de incrementar la eficiencia del programa de detección, así como la detección de posibles diabéticos no diagnosticados. Se hizo una selección previa basada en el Test de Riesgo de Diabetes de lo American Diabetes Association (ADA). A las personas que sumaban 10 puntos o mas se les realizó en ayunas una determinación de glucemia en sangre capilar mediante Glucocord Memory 2®. Se realizaron 1194 test en 58 farmacias, de los que 877 (73,5 por ciento) dieron una puntuación superior a 10. Se efectuaron 748 determinaciones de glucemia capilar, de los que 120 (16,1 por ciento) resultaron mayor o igual a 110 mg/dL. De los 7 parámetros que componen el test ADA, la edad (65 o más años) parece ser el que mayor relación tiene con niveles elevados de glucemia. La campaña ha tenido una excelente aceptación tanto por los farmacéuticos como por los usuarios de oficinas de farmacia, y una notable repercusión social. El test ADA permite un enriquecimiento de la muestra, ya que un 16, 1 por ciento de las determinaciones superaron 110 mg/dL de glucemia. Se detectaron 120 personas con valores de glucemia superiores a 110 que se remitieron al médico para valoración (AU)

From the 4th to the 5th of June 200/ the Official College of Pharmacists of the Province of Pontevedra, along with the Endocrinology and Nutrition Service of the Xeral-Cies Hospital, Vigo, organised a campaign for the detection of non-diagnosed diabetic patients, in the chemists throughout the Province. The aims were to evaluate the role of the local chemist in health educational programs and in the early detection of widespread pathologies and equally to evaluate the usefulness of selection criteria and the influence of risk factors with a view to increasing the efficiency of the detection programme as well as detecting possible non-diagnosed diabetics. A selection was made using the Risk Test of the American Diabetes Association (ADA). For those who scored ten or more points, they were put on a fast to determine the glucose levels in capillary blood with the help of Glucocard Memory 2®. A total of 1194 tests were run in 58 chemists out of which 877 (73.5%) scored higher than 1O.784 glucose blood determinations were carried out, of which 120 (16,1%) were greater or the equivalent of 11O mg/dL. Of the seven components, which make up the ADA test, it would appear that the age factor, 65 years or more, is the one, which has the greatest link to higher levels of glucose. The campaign went down very well with both chemists and clients of the same in addition to a noticeable social acceptance. The ADA test allows for an enrichment of the sample, given that 16.1% exceeded 110 mg/dL of glucose. A total of 120 people were found to have glucose levels in excess of 110 mg/dL. These were sent to the respective doctors for evaluation (AU)